Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab in Children and Young Adults With NF2 and Progressive Vestibular Schwannomas
NCT01767792Phase 2Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- May 2013
- Primary completion
- Jan 2019
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in neurofibromatosis type 2 (NF2), vestibular schwannoma (VS), sponsored by University of Alabama at Birmingham. Started May 2013; status: completed.
02
Drugs
bevacizumab
03
Conditions
neurofibromatosis type 2 (NF2)vestibular schwannoma (VS)
Beyond the preview
Go deeper on NCT01767792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01767792.